Roivant Sciences Ltd. (NASDAQ:ROIV) Maintains "Buy" Rating Amid Positive Momentum
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameRoivant Sciences Ltd.
-
Registration countryBermuda
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









